Search Results
Found 1 results
510(k) Data Aggregation
(54 days)
The Creatine kinase Reagent is to be used in the assessment of cardiac and skeletal muscle diseases, including myocardial infarction and muscle dystrophy.
Not Found
The provided text is a 510(k) clearance letter from the FDA for a Creatine Kinase Reagent. It states that the device has been found substantially equivalent to a predicate device for the assessment of cardiac and skeletal muscle diseases, including myocardial infarction and muscle dystrophy.
However, the document does not contain any information regarding acceptance criteria, reported device performance, sample sizes, expert qualifications, adjudication methods, or training set details. These are typical requirements for device validation studies, but this specific FDA letter is a regulatory clearance document, not a detailed study report.
Therefore, I cannot provide the requested information from the given input.
Ask a specific question about this device
Page 1 of 1